Tirzepatide achieved superior A1C and body weight reductions across all three doses compared to injectable semaglutide in adults with type 2 diabetes
Trial participants taking the highest dose of tirzepatide (15 mg) achieved an A1C reduction of 2.46 percent and weight loss of 12.4 kg (27.3 lb., 13.1 percent), double the weight reduction compared to those taking semaglutide 1 mg
At the lowest dose of tirzepatide (5 mg), participants achieved A1C and body weight reductions of 2.09 percent and 7.8 kg (17.2 lb., 8.5 percent), significantly greater than semaglutide
News provided by
Share this article
Share this article
INDIANAPOLIS, March 4, 2021 /PRNewswire/ Tirzepatide led to superior A1C and body weight reductions from baseline across all three doses compared to injectable semaglutide 1 mg in adults with type 2 diabetes in Eli Lilly and Company s (NYSE: LLY) 40-week SURPASS-2 clinical trial. In topline results from the largest SURPASS trial to date, using the efficacy estimand
Tonometer Market Size is Expected to Reach Around US$ 483 10 Mn by 2028 - Media Releases reseller.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reseller.co.nz Daily Mail and Mail on Sunday newspapers.
U.S. Clinical Laboratory Tests Market Size to Grow at a CAGR of 5.3% During 2020-2025 The Growing Rate of Insufficient Exercise, Consumption of Unhealthy Food, and the Subsequent Rise in Cases of Obesity Which are Contributing to the Growth of U.S. Clinical Laboratory Tests Market.
BriefingWire.com, 3/03/2021 - U.S. Clinical Laboratory Tests Market size in 2019 is estimated to be $6,000 million, growing at a CAGR of 5.3% during the forecast period 2020-2025. Clinical laboratory tests is a group of medical tests carried out in a laboratory equipped with all aspects of laboratory medicine and instruments. These tests are performed on clinical specimen to obtain information about the health of patients, and Diagnosis & treatment of their respective condition. Increasing prevalence of Chronic diseases and technological advancement are the major factors driving the growth of the market. Moreover, rising geriatric population and advancement of R&D activiti
Fasting helps fight diabetes, psychological disorders and other illnesses, say experts
Karachi
March 1, 2021
Although Muslims don’t observe fast in the holy month of Ramazan for medical reasons, fasting in the holy month of Ramazan has hundreds of health benefits – both on the physical and mental well-being of people especially those suffering from diseases like diabetes, hypertension, ischemic heart disease, chronic kidney disease, depression and others illnesses, said local and international health experts at a conference on Sunday.
The experts, however, advised people with health issues to seek pre-Ramazan education and medical advice for safe fasting.
“Scientific evidence proves that fasting promotes blood sugar control and better health by fighting inflammation, enhancing heart health by improving blood pressure, triglycerides and cholesterol levels, boosting brain functions, preventing neurodegenerative disorders, helping weight loss by limiting calorie intake and
Growing army of doctors helping their patients REVERSE DIABETES dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.